Efficacy of Repetitive Trans-spinal Magnetic Stimulation on Axial Motor Symptoms in PD
Trial
N/A
Completed
Jan. 1, 2024
Poised for Parkinson's - an Intervention to Increase Embodied Agency in People With Parkinson's Disease and Their Carers
Trial
N/A
Completed
Dec. 28, 2023
Effectiveness of Rebound Therapy in Parkinson's Patients
Trial
N/A
Completed
Dec. 27, 2023
Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation
Trial
Phase 1
Completed
Dec. 26, 2023
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
Trial
Phase 2
Completed
Dec. 21, 2023
Subthalamic Nucleus Deep Brain Stimulation in Speech Study
Trial
N/A
Unknown
Dec. 21, 2023
Measuring Cortisol Levels in Persons With Parkinson's (PD)
Trial
N/A
Completed
Dec. 21, 2023
Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies
Trial
N/A
Completed
Dec. 21, 2023
Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease
Trial
N/A
Completed
Dec. 21, 2023
Frailty and Cognitive Function in Parkinson's Disease.
Trial
N/A
Completed
Dec. 20, 2023
Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease
Trial
Phase 4
Completed
Dec. 19, 2023
Effects of STN DBS on Cognition and Brain Networks in PD Patients Analyzed Based on EEG and fNIRS
Trial
N/A
Unknown
Dec. 18, 2023
External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait
Trial
N/A
Completed
Dec. 17, 2023
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
Trial
N/A
Unknown
Dec. 14, 2023
The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients
Trial
N/A
Unknown
Dec. 14, 2023
Profile of Depressive Symptoms in Parkinsons Disease
Trial
N/A
Completed
Dec. 13, 2023
PatientSpot Formerly Known as ArthritisPower
Trial
N/A
Unknown
Dec. 12, 2023
Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease
Trial
N/A
Completed
Dec. 11, 2023
A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)
Trial
Phase 1
Completed
Dec. 10, 2023